AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2022
Mar 9, 2022
33148_dirs_2022-03-09_b5bdfc2e-8ad4-4eda-86f2-6a5bdb1e8687.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2021-07-27
Reporting Person: Makker Gotham (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-27 | Common Stock | G | 621500 | — | Disposed | 674901 | Indirect |
Footnotes
F1: The shares were gifted by the reporting person to a nonrevocable trust for the benefit of the reporting person's children. The reporting person has no voting or investment power over all securities owned by the trust.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Capital/Financing Update
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Capital/Financing Update
2026
Mar 2
Earnings Release
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20